Oxodihydropyridyl chroman derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514253, 514256, 514269, 514272, 514275, 514422, 514456, 544230, 544238, 544298, 544318, 544319, 544405, 546269, 548517, 549401, 549404, C07D40512

Patent

active

051439247

ABSTRACT:
Novel chroman derivatives of the formula I ##STR1## in which R.sup.1 to R.sup.6 and Z have the meanings given in Patent Claim 1, and their salts show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.

REFERENCES:
patent: 3707474 (1972-12-01), Razdan et al.
patent: 3947462 (1976-03-01), Arendsen et al.
patent: 3960879 (1976-06-01), Fake
patent: 3973023 (1976-08-01), Fake
patent: 4237162 (1980-12-01), Kabbe
patent: 4486428 (1984-12-01), Eggler et al.
patent: 4782083 (1988-11-01), Cassidy et al.
patent: 4954518 (1990-09-01), Takano et al.
patent: 4971982 (1990-11-01), Attwood et al.
patent: 5013853 (1991-05-01), Gericke
patent: 5043344 (1991-08-01), Englert
patent: 5071871 (1991-12-01), Blarer et al.
Buckle et al., Chem. Abstr. vol. 113 Entry 6311a (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxodihydropyridyl chroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxodihydropyridyl chroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxodihydropyridyl chroman derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-767972

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.